Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials.
Carbapenems have not been comprehensively compared in clinical trials with fourth-generation cephalosporins (4GC) and antipseudomonal penicillins (APP) in the treatment of severe infections (SI) and febrile neutropenia (FN). A systematic review of CENTRAL, EMBASE, MEDLINE and JICST-EPlus for randomi...
Main Authors: | Edwards, S, Clarke, M, Wordsworth, S, Emmas, C |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2008
|
Similar Items
-
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison.
by: Edwards, S, et al.
Published: (2009) -
In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei.
by: Smith, MD, et al.
Published: (1996) -
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis
by: Abdul-Aziz, M.H., et al.
Published: (2016) -
Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
by: Edwards, S, et al.
Published: (2005) -
Reversible acylation of elastase by gamma-lactam analogues of beta-lactam inhibitors
by: Westwood, N, et al.
Published: (1997)